Disparities in Biomarker Testing for Metastatic Colorectal Cancer

Arun Nagarajan, MD, of Cleveland Clinic Florida, discusses new research published in JAMA on biomarker testing disparities in metastatic colorectal cancer.

He explains how disparities in testing can affect overall survival and treatment outcomes for patients with mCRC, and how patient and provider education can play a role in improving the rates of testing.

Видео Disparities in Biomarker Testing for Metastatic Colorectal Cancer канала GI Oncology Now